In my practice, B12 deficiency is rarely a simple nutritional issue, even though it is often presented that way. People arrive having been told they are low, sometimes already supplementing, sometimes receiving injections, and yet something in their system still feels unresolved. There may be fatigue that lingers, mood that does not stabilise in the way expected, cognition that feels dulled or inconsistent, or neurological symptoms that seem disproportionate to what a single nutrient deficiency would explain. When I sit with this clinically, I am not only looking at the number on a blood test, I am listening for the wider pattern, because B12 sits within a much broader network that includes methylation, neurotransmitter metabolism, detoxification, mineral status, digestive function, medication load, and nervous system regulation. It becomes a marker of how the whole system has been adapting over time.

When I bring in methylation and functional genetic testing through the LifeCode Gx reports that I use in my work, the picture immediately becomes more complex and far more meaningful. Within the core methylation cycle, genes such as MTHFR, MTR, and MTRR influence how folate and B12 are activated, recycled, and made available for cellular processes. Variants here can reduce the efficiency of methylation, meaning that B12 may be present in the system, but not effectively utilised where it is needed. BHMT provides an alternative methylation pathway, primarily in the liver, and when this pathway is under strain or less efficient, the demand shifts back onto the folate-dependent cycle, increasing pressure on B12 availability.

This is where the network begins to expand into neurotransmitter metabolism. COMT plays a central role in breaking down dopamine, adrenaline, and noradrenaline, and when COMT is slower, the demand for methyl groups increases significantly. MAOA and MAOB further shape how neurotransmitters are processed, influencing overall nervous system tone and the balance between stimulation and regulation. When these pathways are under pressure, the requirement for methylation support increases, and B12 becomes part of that demand. What appears as a deficiency may in fact reflect a system that is using B12 at a higher rate in order to maintain equilibrium.

The transsulfuration pathway adds another dimension, particularly through genes such as CBS, which influence how homocysteine is directed towards glutathione production. When this pathway is upregulated or imbalanced, it can alter the flow through methylation, again affecting how B12 is utilised within the system. At the same time, detoxification and inflammatory pathways, including those influenced by genes such as IFNG, can increase the overall burden on the body. When inflammation or environmental load is high, resources are redirected towards managing that load, and nutrients such as B12 are drawn into processes that prioritise immediate survival rather than long-term neurological optimisation.

Mineral status is inseparable from this conversation. Genes such as ALPL, which are linked to zinc-dependent enzyme activity and B6 availability, influence how effectively key cofactors are available to support methylation and neurotransmitter balance. Zinc, magnesium, and other minerals are not peripheral, they are foundational to how these pathways function. When they are depleted, the efficiency of methylation and B12 utilisation can be significantly reduced, even if intake appears adequate.

When I step back and look at this as a whole, B12 deficiency begins to look very different. It is no longer a question of intake alone, but of demand, efficiency, and resource allocation within a highly interconnected system.

Alongside this internal landscape, medications form another critical layer. Proton pump inhibitors such as omeprazole and lansoprazole reduce stomach acid, which is essential for releasing B12 from food so that it can bind to intrinsic factor and be absorbed. Over time, this can significantly impair absorption, particularly in individuals whose digestive systems are already compromised. H2 blockers, such as ranitidine and famotidine, act in a similar way, and while often considered milder, their long-term use can still contribute to reduced B12 availability.

Metformin influences B12 through a different mechanism, interfering with absorption in the small intestine, and over time this can lead to a gradual depletion that may only become apparent once neurological or cognitive symptoms emerge. The oral contraceptive pill influences B vitamin status more broadly, including B12, particularly when used over extended periods, and this effect becomes more significant when layered onto methylation inefficiencies.

Anticonvulsant medications can affect B vitamin metabolism, creating a complex interplay in which neurological support and nutrient depletion may be occurring simultaneously. Psychiatric medications can influence appetite, digestion, and nutrient utilisation, and repeated courses of antibiotics can alter the microbiome and the integrity of the gut lining, shaping the terrain in which nutrients are absorbed. When viewed through Timeline Health, what matters is not just the presence of these medications, but their duration, their overlap, and the state of the system when they were introduced.

Digestion remains central to everything we are seeing. B12 requires adequate stomach acid, intrinsic factor, and a healthy gut lining for absorption. When the nervous system is in a chronic state of stress, digestive function is downregulated, stomach acid production can reduce, and the microbiome can shift. Over time, this creates a pattern of malabsorption that cannot be resolved by intake alone. This is where lived experience, stress physiology, and biochemistry converge, shaping the terrain in which deficiencies emerge.

This is also where the conversation around B12 injections needs to be understood more fully. Injections can be extremely helpful, and in some cases essential, particularly when levels are significantly depleted or when neurological symptoms are present, because they bypass parts of the digestive process and can quickly raise circulating B12. However, what I see repeatedly in practice is that they do not always create lasting resolution. If methylation pathways remain under strain, if cofactors such as folate, B6, magnesium, and zinc are not in place, if digestion is still compromised, or if medication effects continue to influence absorption and utilisation, then the body may not be able to effectively use what is being provided. In some cases, particularly where COMT is slower or methylation demand is already high, certain forms of B12 can feel overstimulating, reflecting a system that is not yet ready to process what it is being given. What this reveals is that injections are one piece of a much wider system, and without addressing that wider network, the same patterns can re-emerge over time.

In my work as an integrative health and mental health practitioner, this is where everything comes together. Through genetic testing, detailed case history, and a deep understanding of how the nervous system interfaces with the body, I begin to trace the roots of why B12 has become depleted in that individual. This may involve selecting specific forms of B12 aligned with their genetic profile, supporting cofactors such as folate, B6, magnesium, and zinc, restoring digestive capacity, and working with the nervous system so that the body can shift out of chronic activation and into a state where repair and absorption are possible.

There is something deeply important in reframing B12 deficiency in this way. Rather than seeing it as a problem to be corrected in isolation, it becomes part of a wider conversation about how the body is functioning as a whole. It reflects how energy is being generated and sustained, how the brain and nervous system are being supported, and how resilient or depleted the terrain has become over time. When we listen at that level, we move beyond replacement and into understanding.

This is the essence of working at the grassroots level. Whether described as upstream or grassroots, it is about understanding the conditions that allowed the deficiency to develop, and working with those conditions directly. In that context, B12 becomes more than a vitamin. It becomes a signal within a much larger system, guiding us towards a deeper and more sustainable form of healing, where the aim is not simply correction, but coherence across the whole.

I am right here…